Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma.

Ozaki K, Toshikuni N, George J, Minato T, Matsue Y, Arisawa T, Tsutsumi M.

J Cancer. 2014 Mar 4;5(3):221-30. doi: 10.7150/jca.7691.

2.

Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma.

Tamai T, Uto H, Takami Y, Oda K, Saishoji A, Hashiguchi M, Kumagai K, Kure T, Mawatari S, Moriuchi A, Oketani M, Ido A, Tsubouchi H.

World J Gastroenterol. 2011 Nov 28;17(44):4890-8. doi: 10.3748/wjg.v17.i44.4890.

3.

Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.

Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K.

World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.

4.

Serum endocan as a survival predictor for patients with liver cirrhosis.

Toshikuni N, Ozaki K, George J, Tsutsumi M.

Can J Gastroenterol Hepatol. 2015 Nov-Dec;29(8):427-30.

5.

Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis.

Nault JC, Guyot E, Laguillier C, Chevret S, Ganne-Carrie N, N'Kontchou G, Beaugrand M, Seror O, Trinchet JC, Coelho J, Lasalle P, Charnaux N, Delehedde M, Sutton A, Nahon P.

Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1343-52. doi: 10.1158/1055-9965.EPI-13-0179.

6.

Endocan expression correlated with poor survival in human hepatocellular carcinoma.

Huang GW, Tao YM, Ding X.

Dig Dis Sci. 2009 Feb;54(2):389-94. doi: 10.1007/s10620-008-0346-3.

PMID:
18592377
7.

Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma.

Imamura H, Matsuyama Y, Miyagawa Y, Ishida K, Shimada R, Miyagawa S, Makuuchi M, Kawasaki S.

Br J Surg. 1999 Aug;86(8):1032-8.

PMID:
10460639
8.

Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.

Bertino G, Neri S, Bruno CM, Ardiri AM, Calvagno GS, Malaguarnera M, Toro A, Malaguarnera M, Clementi S, Bertino N, Di Carlo I.

Minerva Med. 2011 Oct;102(5):363-71. Review.

PMID:
22193346
9.

Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.

Chon YE, Choi GH, Lee MH, Kim SU, Kim DY, Ahn SH, Kim KS, Choi JS, Han KH, Chon CY, Park JY.

Int J Cancer. 2012 Nov 15;131(10):2332-41. doi: 10.1002/ijc.27507.

10.

Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.

Lee S, Rhim H, Kim YS, Kang TW, Song KD.

Liver Int. 2016 Apr;36(4):580-7. doi: 10.1111/liv.12991.

PMID:
26503910
11.

Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma.

Shimada M, Takenaka K, Fujiwara Y, Gion T, Kajiyama K, Maeda T, Shirabe K, Sugimachi K.

Cancer. 1996 Nov 15;78(10):2094-100.

13.

The Predictive Power of Serum α-Fetoprotein and Des-γ-Carboxy Prothrombin for Survival Varies by Tumor Size in Hepatocellular Carcinoma.

Tsugawa D, Fukumoto T, Kido M, Takebe A, Tanaka M, Kuramitsu K, Matsumoto I, Ajiki T, Koyama T, Ku Y.

Kobe J Med Sci. 2016 Mar 7;61(5):E124-31.

14.

High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.

Lv Y, Wang W, Jia WD, Sun QK, Huang M, Zhou HC, Xia HH, Liu WB, Chen H, Sun SN, Xu GL.

Eur J Surg Oncol. 2013 Oct;39(10):1129-35. doi: 10.1016/j.ejso.2013.06.023.

PMID:
23916473
15.

Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.

Lee YK, Kim SU, Kim DY, Ahn SH, Lee KH, Lee DY, Han KH, Chon CY, Park JY.

BMC Cancer. 2013 Jan 3;13:5. doi: 10.1186/1471-2407-13-5.

16.

Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.

Hamamura K, Shiratori Y, Shiina S, Imamura M, Obi S, Sato S, Yoshida H, Omata M.

Cancer. 2000 Apr 1;88(7):1557-64.

PMID:
10738213
17.

Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.

Giannini EG, Marenco S, Borgonovo G, Savarino V, Farinati F, Del Poggio P, Rapaccini GL, Anna Di Nolfo M, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group..

Hepatology. 2012 Oct;56(4):1371-9. doi: 10.1002/hep.25814.

PMID:
22535689
18.
19.

Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.

Bhattacharjya S, Bhattacharjya T, Quaglia A, Dhillon AP, Burroughs AK, Patch DW, Tibballs JM, Watkinson AF, Rolles K, Davidson BR.

Dig Surg. 2004;21(2):152-9; discussion 159-60.

PMID:
15166485
20.

Des-gamma-carboxy prothrombin identified by P-11 and P-16 antibodies reflects prognosis for patients with hepatocellular carcinoma.

Takeji S, Hirooka M, Koizumi Y, Tokumoto Y, Abe M, Ikeda Y, Nadano S, Hiasa Y, Onji M.

J Gastroenterol Hepatol. 2013 Apr;28(4):671-7. doi: 10.1111/jgh.12076.

PMID:
23215762

Supplemental Content

Support Center